Skip to main content
. 2018 Oct 31;22(Suppl 3):S139–146. doi: 10.5213/inj.1836228.114

Fig. 4.

Fig. 4.

Effect of dexmedetomidine on D1 dopamine receptor (D1DR) in the pre-frontal cortex (PFC), striatum, and substantia nigra (SN). Upper panel: The results of band detection using the enhanced chemiluminescence detection kit in PFC (left), striatum (middle), and SN (right). Lower panel: The relative expression of D1 dopamine receptor in each group. A, control group; B, sleep deprivation group; C, sleep deprivation and 0.5 μg/kg dexmedetomidine-treated group; D, sleep deprivation and 1 μg/kg dexmedetomidinetreated group; E, sleep deprivation and 2 μg/kg dexmedetomidine-treated group. *P<0.05 compared to the control group. # P<0.05 compared to the sleep deprivation group.